COVID‐19 vaccination in patients with rheumatic diseases: Vaccination rates, patient perspectives, and side effects

Abstract

COVID-19 vaccination is associated with no increased risk of side effects in any particular disease or drug therapy, therefore vaccination should be encouraged in patients with rheumatic disease. In addition, younger age is associated minimally, while mRNA vaccine is associated with increased side effects.